topical diclofenac solution (Pennsaid速)	vehicle control solution (carrier with no diclofenac)	Pain on walking	19926	20090	There was a significantly greater improvement in score with topical diclofenac compared to vehicle control (Table 2) for pain on walking (-1.2 vs. -0.8; p = 0.014).
topical diclofenac solution (Pennsaid速)	vehicle control solution (carrier with no diclofenac)	Dry skin at the application site	21275	21473	The major adverse effect reported was dry skin at the application site, occurring in 42/107 (39.3%) and 23/109 (21.1%; p = 0.004) of topical diclofenac and vehicle control participants, respectively
topical diclofenac solution (Pennsaid速)	vehicle control solution (carrier with no diclofenac)	good or very good PGA response and OMERACT-OARSI responder	20297	20541	The topical diclofenac group had a significantly greater number of participants with good or very good PGA response (43.8% vs. 16.8%; p <0.0001) compared to the vehicle control group and of OMERACT-OARSI responders (65.7% vs. 49.5%; p = 0.017).
topical diclofenac solution (Pennsaid速)	vehicle control solution (carrier with no diclofenac)	50% reduction in pain	20091	20296	The response rate for at least a 50% reduction in pain (Table 3) was significantly greater following topical diclofenac treatment compared to vehicle control (46/105 [43.8%] vs. 27/107 [25.2%]; p = 0.004).
